Sharmilee Patel

Prior to joining Oxford Biomedica Sharmilee spent 20 years with contract manufacturing organizations, such as Fujifilm Diosynth Biotechnologies (previously Covance / Diosynth Biotechnology / Merck Biomanufacturing Network), WuXi AppTec, and Cytovance Biologics focusing on CMC services for biologics, cell and gene therapies as well as consulting. At Oxford, Biomedica Sharmilee focuses on CDMO services and lentiviral platform technology licensing.